REVIEW PAPER
Environmental factors and allergic diseases
More details
Hide details
1
Department of Dermatology, University of Medical Science, Poznan, Poland
Corresponding author
Dorota Jenerowicz
Department of Dermatology, University of Medical Science, Poznan, Poland
Ann Agric Environ Med. 2012;19(3):475-481
KEYWORDS
ABSTRACT
An objective of this article is a review of contemporary knowledge on various environmental factors, that influence prevalence and course of allergic diseases, like asthma, allergic rhinitis, atopic dermatitis and also contact dermatitis. Surrounding climate may directly influence each patient, but also determines type of flora and fauna within particular geographical regions and thus affects sources of airborne and food allergens. Epidemiological studies suggest that there is a strong relationship between air pollution and development and exacerbation of asthma and other allergic diseases – main attention has been concentrated on gaseous materials such as ozone (O3) and nitrogen dioxide (NO2), as well as particulate matter (PM), generated by car traffic and industry. Diesel exhaust particulate (DEP) has the ability to bind proteins and may serve as a potential carrier of allergens, penetrating deep into respiratory tract. Among the most extensively studied environmental factors influencing allergy are airborne allergens: dust mites, pollens, fungi and animal dander. Foods may elicit both true IgE-mediated allergy and also various non-immunological reactions, associated with direct release of mediators or toxic activity. It has been estimated, that over 85 000 chemicals are recognized in the human environment and they may act as contact allergens or irritants, causing allergic or non-allergic contact dermatitis. Among them metals, fragrances, preservatives, botanicals and paraphenylenediamine are considered as the most significant. Infections have always been associated with etiopathogenesis of allergic diseases and they may contribute to exacerbation of their course.
REFERENCES (92)
1.
Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. EAACI (the European Academy of Allergology and Cinical Immunology) nomenclature task force. Allergy. 2001; 56: 813-824.
2.
Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol. 1998; 138: 107-113.
3.
Renz H, Conrad M, Brand S, Teich R, Garn H, Pfefferle PI. Allergic diseases, gene-environment interactions. Allergy. 2011; 66 Suppl 95: 10-12.
4.
Koppelman GH. Gene by environment interaction in asthma. Curr Allergy Asthma Rep. 2006; 6: 103-111.
5.
Los H, Postmus PE, Boomsma DI. Asthma genetics and intermediate phenotypes: a review from twin studies. Twin Res. 2001; 4: 81-93.
6.
Schnuch A. Genetics of contact allergy. Hautarzt. 2011; 62: 732-738.
7.
Breiteneder H, Scheirer O. Enviromental pollution and pollen allergy – a possible link. Allergologie. 1990; 13: 434-441.
8.
Vocks S. Climatotherapy in atopic eczema. In: Ring J, Przybilla B, Ruzicka T. Handbook of atopic eczema. Springer-Verlag Berlin Heidelberg New York 2006, 507-520.
9.
Silny W. Obecne poglądy na etiologię i patomechanizm atopowego zapalenia skóry. Postępy w alergologii. Wyd. Press, Warszawa 1994; 298-308.
10.
Engst R, Vocks E. High mountain climatotherapy for dermatological and allergic diseases – results, impacts and influence on immunity. Rehabilitation. 2000; 39:215-222.
11.
Eberlein-König E, Huss-Marp J, Behrendt H, Ring J. Environmental pollution and atopic eczema. In: Ring J, Przybilla B, Ruzicka T. Handbook of atopic eczema. Springer-Verlag Berlin Heidelberg New York 2006, 381-388.
12.
Takizawa H: Impact of air pollution on allergic disease. Korean J Intern Medicine. 2011; 26: 262-273.
13.
D’Amato G, Cecchi L. Effects of climate change on environmental factors in respiratory allergic diseases. Clin Exp Allergy. 2008; 38: 1264-1274.
14.
D’Amato G, Cecchi L, D’Amato M, Liccardi G. Urban air pollution and climate change as environmental risk factors of respiratory allergy: an update. J Investig Allergol Clin Immunol. 2010; 20: 95-102.
15.
Kasznia-Kocot J, Kowalska M, Górny RL, Niesler A, Wypych-Ślusarska A. Environmental risk factors for respiratory symptoms and childhood asthma. Ann Agric Environ Med. 2010; 17: 221-229.
16.
Bernstein DI. Traffic-related pollutants and wheezing in children. J Asthma. 2012; 49: 5-7.
17.
Lubitz S, Schober W, Pusch G, Effner R, Klopp N, Behrendt H et al. Polycyclic aromatic hydrocarbons from diesel emissions exert proallergic effects in birch pollen allergic individuals through enhanced mediator release from basophils. Environ Toxicol. 2010; 25:188-197.
18.
Wahn U, Nickel R, Illi S, Lau S, Grüber C, Hamelmann E. Primary Prevention of Atopy. In: Ring J, Przybilla B, Ruzicka T. Handbook of atopic eczema. Springer-Verlag Berlin Heidelberg New York 2006; 433-438.
19.
Silny W, Czarnecka-Operacz M, Gliński W, Samochocki Z, Jenerowicz D. Atopowe zapalenie skóry – współczesne poglądy na patomechanizm oraz metody postępowania diagnostyczno-leczniczego. Stanowisko grupy specjalistów Polskiego Towarzystwa Dermatologicznego. Post Dermatol Alergol. 2010; 5: 365-383.
20.
Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy. 2006; 61: 969-987.
21.
Darsow U, Ring J. Airborne and dietary allergens in atopic eczema: a comprehensive review of diagnostic tests. Clin Dermatol. 2000; 25: 544-551.
22.
Silny W, Czarnecka-Operacz M. Alergeny powietrznopochodne i ich znaczenie w powstawaniu zmian skórnych u chorych na atopowe zapalenie skóry. Alergia Astma Immunol. 2001; 6: 81-85.
23.
Alp H, Yu BH, Grant EN, Rao V, Moy JN. Cockroach allergy appears early in life in inner-city children with recurrent wheezing. Ann Allergy Asthma Immunol. 2001; 86: 51-58.
24.
Beck HJ, Korsgaard J. Atopic dermatitis and house dust mites. Br J Dermatol. 1989; 120: 245-251.
25.
Hallas TE, Gislason T, Gislason D. Mite allergy and mite exposure in Iceland. Ann Agric Environ Med. 2011; 18:13-17.
26.
Silny W. Etiopatomechanizm atopowego zapalenia skóry. Postępy w alergologii – II. Medpress, Warszawa 1997; 265-269.
27.
Mygind N, Dahl R, Pedersen S. Źrodła alergenów. In: Kruszewski J, Silny W. Alergologia. Urban&Partner, Wrocław 1988; 81.
28.
Ziello C, Sparks TH, Estrella N, Belmonte J, Bergmann KC, Bucher E et al. Changes to airborne pollen counts across Europe. PLoS One. 2012;7: 34076.
29.
Pérez-Badia R, Vaquero C, Sardinero S, Galán C, García-Mozo H. Intradiurnal variations of allergenic tree pollen in the atmosphere of Toledo (central Spain). Ann Agric Environ Med. 2010; 17: 269-275.
30.
Smith M, Emberlin J, Stach A, Czarnecka-Operacz M, Jenerowicz D, Silny W. Regional importance of Alnus pollen as an aeroallergen: a comparative study of Alnus pollen counts from Worcester (UK) and Poznań (Poland). Ann Agric Environ Med. 2007;14:123-128.
31.
A, García-Mozo H, Prieto-Baena JC, Czarnecka-Operacz M, Jenerowicz D, Silny W et al. Prevalence of Artemisia species pollinosis in western Poland: impact of climate change on aerobiological trends, 1995-2004. J Investig Allergol Clin Immunol. 2007; 17: 39-47.
32.
Mohr LC. Hypersensitivity pneumonitis. Curr Opin Pulm Med. 2004; 10: 401-411.
33.
Dutkiewicz J, Cisak E, Sroka J, Wójcik-Fatla A, Zając V. Biological agents as occupational hazards – selected issues. Ann Agric Environ Med. 2011; 18: 286-293.
34.
Ortolani C, Bruijnzeel-Koomen C, Bengtsson U, Bindslev-Jensen C, Björkstén B, Høst A et al. Controversial aspects of adverse reactions to food. European Academy of Allergology and Clinical Immunology (EAACI) Reactions to Food Subcommittee. Allergy. 1999; 54: 27-45.
35.
Bindslev-Jensen C, Ballmer-Weber BK, Bengtsson U, Blanco C, Ebner C, Hourihane J et al. Standardization of food challenges in patients with immediate reactions to foods – position paper from the European Academy of Allergology and Immunology. Allergy. 2004; 59: 690-697.
36.
Kaczmarski M, Wasilewska J, Jarocka-Cyrta E, Cudowska B, Żur E, Matuszewska E et al. Polish statement on food allergy in children and adolescents. Post Dermatol Alergol. 2011; 5: 331-367.
37.
Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol. 2006; 117: 470-475.
38.
Pałgan K, Bartuzi Z. Genetic aspects of food allergy. Post Dermatol Alergol. 2011; 2: 103-106.
39.
Sicherer SH, Furlong TJ, Maes HH. Genetics of peanut allergy: a twin study. J Allergy Clin Immunol. 2000; 106: 53-56.
40.
Rosińska-Więckowicz A, Czarnecka-Operacz M. Disease extent and severity in patients with atopic dermatitis and food allergy. Post Dermatol Alergol. 2011; 5: 382-388.
41.
Zaknun D, Schroecksnadel S, Kurz K, Fuchs D. Potential role of antioxidant food supplements, preservatives and colorants in the pathogenesis of allergy and asthma. Int Arch Allergy Immunol. 2012; 157: 113-124.
42.
Czarnecka-Operacz M, Jenerowicz D, Silny W. Oral allergy syndrome in patients with airborne allergy treated with specific immunotherapy. Acta Dermatovenerol Croat. 2008; 16: 19-24.
43.
Kugler C. Dietary management of atopic eczema. Handbook of atopic eczema. Springer-Verlag Berlin Heidelberg New York 2006, 534-537.
44.
Breiteneder H, Hoffmann-Sommergruber K, O’Riordan G, Susani M, AhornH, Ebner C et al. Molecular characterization of Api g 1, the major allergen of celery (Apium graveolens) and its immunological and structural relationships to a group of 17 kDa tree pollen allergens. Eur J Biochem. 1995; 233: 484.
45.
Werfel T, Breuer K. Role of food allergy in atopic eczema. Handbook of atopic eczema. Springer-Verlag Berlin Heidelberg New York 2006, 399-402.
46.
Buczyłko K, Wagner A. Przydatność zestawu Polycheck plus zawierającego alergeny rBet v1 i rBet v2 przed immunoterapią pyłkowicy brzozowej. Post Dermatol Alergol. 2011; 1: 75-82.
47.
Karamloo F, Schmitz N, Scheurer S, Foetisch K, Hoffmann A, Haustein D et al. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins. J Allergy Clin Immunol. 1999; 104: 991-999.
48.
Eriksson NE, Formgren H, Svenonius E. Food hypersensitivity in patients with pollen allergy. Allergy. 2002; 37: 437-443.
49.
Custovic A, Murray C, Simpson A. Allergy and infection: understanding their relationship. Allergy. 2005; 60 Suppl 79:10-3.
50.
Bręborowicz A. Częste infekcje a astma i choroby alergiczne u dzieci. Post Dermatol Alergol. 2009; 5: 378-381.
51.
Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005; 201: 937-947.
52.
Zambrano JC, Carper HT, Rakes GP, Patrie J, Murphy DD, Platts-Mills TA et al. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE. J Allergy Clin Immunol. 2003; 111: 1008.
53.
Johnston NW, Johnston SL, Duncan JM, Greene JM, Kebadze T, Keith PK et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol. 2005; 115: 132-138.
54.
Everard ML. The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children. Curr Opin Allergy Clin Immunol. 2006; 6: 56-61.
55.
Gern JE, Lemanske RF. Infectious triggers of pediatric asthma. Pediatr Clin N Am. 2003; 50: 555-575.
56.
Bręborowicz A. Rola zakażeń w patogenezie astmy oskrzelowej. Przew Lek. 2004; 1:73-79.
57.
Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010; 125: 4-13.
58.
Adamek-Guzik T, Guzik T, Czerniawska-Mysik G, Pryjma J. Znaczenie obniżonej odporności na infekcje w patogenezie atopowego zapalenia skóry: rola Staphylococcus aureus. Alergia Astma Immunol. 2001; 6: 169-179.
59.
Breuer K, Wittmann M, Bösche B, Kapp A, Werfel T. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy. 2000; 55: 551-555.
60.
Leung DYM. Atopic dermatitis and the immmune system: the role of superantigens and bacteria. J Am Acad Dermatol. 2001; 45: 13-16.
61.
Jensen-Jarolim E, Poulsen LK, With H, Kieffer M, Ottevanger V, Stahl Skov P. Atopic dermatitis on the face, scalp and neck: type I reaction to the yeast Pityrosporum ovale? J Allergy Clin Immunol. 1992; 89: 44-51.
62.
Schmid-Grendelmeier P, Scheynius A, Crameri R. The role of sensitization to Malassezia sympodialis in atopic eczema. Chem Immunol Allergy. 2006; 91: 98-109.
63.
Rup E, Skóra M, Krzyściak P, Macura AB. Ocena jakościowa występowania grzybów z rodzaju Malassezia na skórze u pacjentów z łuszczycą zwyczajną. Post Dermatol Alergol 2010; 4: 264-268.
64.
Strachan DP Hay fever, hygiene and household size. Br Med J. 1989; 299: 1259-1260.
65.
Liu AH. Hygiene theory and allergy and asthma prevention. Paediatr Perinat Epidemiol. 2007; 21 Suppl 3:2-7.
66.
Grammatikos AP. The genetic and environmental basis of atopic diseases. Ann Med. 2008;40:482-495.
67.
Bresciani M, Parisi C, Manghi G, Bonini S. The hygiene hypothesis: does it function worldwide? Curr Opin Allergy Clin Immunol. 2005; 5: 147-51.
68.
Sudre B, Vacheyrou M, Braun-Fahrländer C, Normand AC, Waser M, Reboux G et al. High levels of grass pollen inside European dairy farms: a role for the allergy-protective effects of environment? Allergy. 2009; 6: 1068-1073.
69.
Fishbein AB, Fuleihan RL. The hygiene hypothesis revisited: does exposure to infectious agents protect us from allergy? Curr Opin Pediatr. 2012; 24: 98-102.
70.
Thyssen JP, Linneberg A, Menne T, Johansen JD. The epidemiology of contact allergy in general population – prevalence and main findings. Contact Dermatitis. 2007; 57: 287-299.
71.
Chomiczewska D, Kieć-Świerczyńska M, Kręcisz B. Kontaktowe zapalenie skóry z podrażnienia. Część I – epidemiologia, etiopatogeneza i obraz kliniczny. Medycyna Pracy. 2008; 59: 409 – 419.
72.
Śpiewak R. Wyprysk kontaktowy. Post Dermatol Alergol. 2009; 5: 375-377.
73.
Kieć-Świerczyńska M. Co nowego w alergii kontaktowej? Post Dermatol Alergol. 2009; 5: 344-346.
74.
Rudzki E. Alergia kontaktowa. Przegląd Alergologiczny. 2005, 2: 30-33.
75.
Kieć-Świerczyńska M, Kręcisz B, Chomiczewska D, Sobala W. Trends in allergy to the 10 most frequent contact allergens in patients examined at the Nofer Institute, Lodz, Poland in 1996-2009. Post Dermatol Alergol. 2012; 1: 19-24.
76.
Garg S, McDonagh AJG, Gawkrodger DJ. Age- and sex-related variations in allergic contact dermatitis to common allergens. Contact Dermatitis. 2009; 61: 46-7.
77.
Basko-Plluska JL, Thyssen JP, Schalock PC. Cutaneous and systemic hypersensitivity reactions to metallic implants. Dermatitis. 2011; 22: 65-79.
78.
Klimańska M, Żmudzińska M, Jenerowicz D, Czarnecka-Operacz M. The importance of exposure to contact allergens in patients with allergic contact dermatitis. Post Dermatol Alergol. 2011; 3: 203-211.
79.
Ortiz KJ, Yiannias JA. Contact dermatitis to cosmetics, fragrances, and botanicals. Dermatol Ther. 2004; 17: 264-271.
80.
Kind F, Scherer K, Bircher AJ. Contact dermatitis to para-phenylenediamine in hair dye following sensitization to black henna tattoos – an ongoing problem. J Dtsch Dermatol Ges. 2012; 10: 572-527.
81.
Corrente S, Moschese V, Chianca M, Graziani S, Iannini R, La Rocca M, Chini L. Temporary henna tattoo is unsafe in atopic children. Acta Paediatr. 2007; 96: 469-471.
82.
Janssens V, Morren M, Dooms-Goossens A, Degreef H. Protein contact dermatitis: myth or reality?. Br J Dermatol. 1995; 132: 1-6.
83.
Levin C, Warshaw E. Protein contact dermatitis: allergens, pathogenesis, and management. Dermatitis. 2008; 19: 241-251.
84.
Broding HC, Frank P, Hoffmeyer F, Bünger J. Course of occupational asthma depending on the duration of workplace exposure to allergens – a retrospective cohort study in bakers and farmers. Ann Agric Environ Med. 2011; 18: 35-40.
85.
Kieć-Swierczyńska M, Kręcisz B, Potocka A, Świerczyńska-Machura D, Dudek W, Pałczyński C. Psychological factors in allergic skin diseases. Med Pr. 2008; 59: 279-285.
86.
Staubach P, Dechene M, Metz M, Magerl M, Siebenhaar F, Weller K et al. High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol. 2011; 91: 557-561.
87.
Pietras T, Panek M, Witusik A, Wujcik R, Szemraj J, Górski P, Kuna P. Analysis of the correlation between level of anxiety, intensity of depression and bronchial asthma control. Post Dermatol Alergol. 2011; 1: 15-22.
88.
Sęk H. Wprowadzenie do psychologii klinicznej. Wydawnictwo Naukowe Scholar, Warszawa 2001.
89.
Czubalski K., Czubalska J. Atopowe zapalenie skóry w aspekcie psychosomatycznym. Post Dermatol Alergol. 1989; 6: 149-155.
90.
Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006; 60: 984-992.
91.
Talarczyk M, Silny W, Rajewski A, Piotrowski M. Poziom aspiracji i rozwój intelektualny u dzieci i młodzieży z atopowym zapaleniem skóry. Post Dermatol Alergol. 1992; 9: 203-208.
92.
Kelsay K, Klinnert M, Bender B. Addressing psychosocial aspects of atopic dermatitis. Immunol Allergy Clin North Am. 2010; 30: 385-396.